A4250, an IBAT Inhibitor in Pediatric Cholestasis

Clinical trial NCT02630875 · COMPLETED

Trial details

NCT number: NCT02630875
Sponsor: Albireo
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pediatric Cholestasis

Start date: 2015-08-01
Primary completion: 2017-03-17
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.